Cite
HARVARD Citation
Thuluva, S. et al. (2022). A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E's Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine (TyphiBEVTM) in healthy infants, children, and adults in comparison with a licensed comparator. Human vaccines & immunotherapeutics. 18 (5), p. . [Online].